The Molecular Biology of Human Immunodeficiency Virus Type 1 Infection
- 31 January 1991
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (5) , 308-317
- https://doi.org/10.1056/nejm199101313240506
Abstract
HUMAN immunodeficiency virus type 1 (HIV-1) has been clearly identified as the primary cause of the acquired immunodeficiency syndrome (AIDS).1 , 2 Unlike any other infectious disease in modern medical history, AIDS has galvanized the concern and efforts of physicians, scientists, and the lay public alike. The magnitude of the mounting AIDS problem is indeed sobering. Since the initial clinical reports in the summer of 1981, over 132,000 cases of AIDS have been diagnosed in the United States, and nearly half the patients have died as a result of their disease.3 In addition, between 1 and 2 million Americans are now infected . . .Keywords
This publication has 114 references indexed in Scilit:
- Immunologic issues in anti-retroviral therapyImmunology Today, 1990
- Animal models for AIDSImmunology Today, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesNature, 1990
- HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprisesImmunology Today, 1989
- Single amino-acid changes in HIV envelope affect viral tropism and receptor bindingNature, 1989
- Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4Nature, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The trans-activator gene of the human T cell lymphotropic virus type III is required for replicationCell, 1986
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984